Follow-up studies on the 10-year cohorts showed that patients with a high level of CD8+ T cells achieved significantly higher survival rates (Figures 1A–D), which demonstrated that CD8+ T cells plays a protective role against ccRCC. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.